Formulation Featured Articles

  1. mRNA-Lipid Nanoparticles Circumvent Viral Vector Limitations 6/1/2022

    Both physical and chemical nonviral gene delivery systems for ex vivo genetic modification offer advantages over viral vectors, including smaller scale production and the low risk of immunogenicity.

  2. FDA Releases Draft Guidance On CMC For Individualized ASO Therapies 4/26/2022

    A new FDA guidance released in Dec. 2021 acknowledges the difficulties inherent in manufacturing individualized antisense oligonucleotide (ASO) treatments and offers researchers and manufacturers the opportunity to create policies and procedures that are more likely to be condoned by the FDA in an IND submission.

  3. The Current Landscape Of mRNA Vaccines In Clinical Research 3/17/2022

    With the Pfizer-BioNTech and Moderna products, mRNA vaccines made global headlines in 2021 in the fight against COVID-19. As we recognize National Immunization Awareness Month, this article shares how mRNA vaccines currently in clinical research and clinical trials may be soon used to fight HIV-1, herpes, cancer, and more.

  4. Translation Of RNA Medicines From Design To Clinic 3/2/2022

    Understand the advantages and challenges of lipid-based delivery systems for successful translation of RNA into clinical development.

  5. How mRNA Technology Is Shaping The Future Of Medicine 1/4/2022

    Discover how mRNA technologies open the doors to a whole range of new gene therapies and the role of lipid nanoparticles (LNPs) in current and future developments.

  6. Are Dry Powder Biologics Ready For Primetime? 9/21/2020

    A new approach to freezing biopharmaceuticals into fine, dry powders holds promise for flexible therapeutic form factors, efficacy improvements, and supply and distribution chain efficiencies. It's a particularly timely development in the age of COVID-19.

  7. FrymaKoruma At Interphex 2013 Highly Flexible And Hygienic Processes 3/11/2013

    The FrymaKoruma MZ toothed colloid mill will be the centrepiece of the Romaco FrymaKoruma exhibit at this year’s Interphex in New York (USA). This milling system is used for wet grinding of suspensions and other products of almost any viscosity.

  8. New 1.3-Micron Kinetex Core-Shell Media Delivers Superior UHPLC Performance 1/15/2013

    Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the addition of 1.3-micron UHPLC columns to its Kinetex core-shell product line.

  9. Top Pharma And Biotech Firms Trust CompacT Automated Cell Culture To Generate Their Cell Lines 1/11/2013

    TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications today announced that with its latest installation of CompacT SelecT™, the technology remains the most widely adopted system for automated culture of adherent cell lines in T-flasks, used by major pharmaceutical and biotech companies worldwide.

  10. 'Coding For Compliance' Expands Social Reach 1/7/2013

    Domino North America has expanded the social media reach of their educational campaign “Coding for Compliance,” by adding Facebook and Twitter pages.